Marcello Deraco, MD
Surgical Oncologist, Responsible for Peritoneal Malignancies, Fondazione IRCCS Istituto Nazionale dei Tumori: via Venezian, 1 20133 Milano, Italy
Dr. Marcello Deraco (24 August 1962) is currently Responsible for Peritoneal Surface Malignancies at the Fondazione IRCCS Istituto Nazionale dei Tumori Milano-Italy and Professor of Digestive Tract Surgery at the University of Roma Tor Vergata.
Graduated in Medecine on July 1987; Post Graduated in General Surgery on October 1992 and in Oncology on 1993.
Dr. Deraco dedicated many clinical and scientific efforts during 25 years in the field of Peritoneal Surface Malignancies; as Principal Investigator he carried out several clinical-biological studies publishing more than 150 papers or book chapters and achieving interesting results on patient outcomes. As Director of the 2006 PSOGI Consensus Conference on Peritoneal Surface Malignancies he actively contributed to optimize recommendations and guide lines in this area. Actually he is Principal Investigator of the following clinical-biological studies: 1) Peritoneal Mesothelioma: Optimize Outcomes by the Integration of new Prognostic Factors and Potential Therapeutic Targets in a Individualized Treatment based on Molecular Characterization and Chemosensitivity Profile on Primary Cultures. (Ricerca Finalizzata 2009 Project Code: RF-2009-1546664 Duration 2011-2016); 2) Pseudomyxoma Peritonei: Prognostic Analysis of Micro-RNA and Other Biological Factors Using Tissue Microarray (NORD's MAC 2011 pseudomyxoma peritonei grant award. duration 2012-2014). He is also investigator of several other studies.
Furthermore, Dr. Deraco is Coordinator of the Peritoneal Malignancy Scientific Group of the SITILO. (Italian Society for Locoregional Treatment) and Coordinator of the Peritoneal Mesothelioma Scientific Group of the GIMe (Italian Mesothelioma Group). He the Secretary of SITILO: (Italian Society for Loco Regional Cancer Therapy) and Member of the Executive Board of PSOGI (Peritoneal Surface Oncology Group International) and GIMe (Italian Mesothelioma Group); Member of several scientific societies as SSO (Society of Surgical Oncology), ESSO (European Society of Surgical Oncology) and SICO (Italian Society of Surgical Oncology).